Spyre Therapeutics, Inc. · NASDAQ:SYRE
Henderson Michael Thomas sold 20,000 Spyre Therapeutics, Inc. shares (Form 4)
Traded Jun 22, 2026 · Filed Jun 23, 2026
On Jun 22, 2026, Henderson Michael Thomas (Director) sold 20,000 Spyre Therapeutics, Inc. shares at US$100.00 for US$2M under a trading plan, leaving 68,606 shares. Filed Jun 23, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$100.00
- Value
- US$2M
- Holding after
- 68,606 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Sale | 20,000 | US$100.00 | 68,606 | Direct |
Source
Related
- Spyre Therapeutics, Inc.
- Henderson Michael Thomas
- Spyre Therapeutics, Inc. shareholders
- Form 4 · Henderson Michael Thomas · May 8, 2026
- Schedule 13D/A · Harwin Peter Evan · Oct 9, 2026
- Form 4 · Burrows Scott L · Oct 2, 2026
- Form 4 · King-Jones Heidy · Oct 2, 2026
- Form 4 · Turtle Cameron · Oct 2, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Oct 1, 2026